- Supported exchanges /
- KQ /
- 166480.KQ
CORESTEM Inc (166480 KQ) stock market data APIs
CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company also engages in the development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases. The company was formerly known as Corestem, Inc. CORESTEMCHEMON Inc. was founded in 2003 and is based in Seongnam-si, South Korea.
CORESTEM Inc Financial Data Overview
11310 | |
11540 | |
- | |
11820 | |
11290 | |
5720-15610 | |
285 682 M | |
24 756 K | |
30 431 M | |
-622.0085 | |
0.791 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CORESTEM Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 30 431 M
- EBITDA -17 660 936 192
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CORESTEM Inc Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get CORESTEM Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: